Takata, A., Miyake, N., Tsurusaki, Y., Fukai, R., Miyatake, S., Koshimizu, E., … Matsumoto, N. (2018). Integrative Analyses of De Novo Mutations Provide Deeper Biological Insights into Autism Spectrum Disorder. Cell Reports, 22(3), 734-747. https://doi.org/10.1016/j.celrep.2017.12.074 (Original work published 2018)

Fleck, D., Eliassen, J., Guerdjikova, A., Mori, N., Williams, S., Blom, T., … McElroy, S. (2019). Effect of lisdexamfetamine on emotional network brain dysfunction in binge eating disorder. Psychiatry Research. Neuroimaging, 286, 53-59. https://doi.org/10.1016/j.pscychresns.2019.03.003 (Original work published 2019)

McElroy, S., Guerdjikova, A., Mori, N., & Romo-Nava, F. (2019). Progress in Developing Pharmacologic Agents to Treat Bulimia Nervosa. CNS Drugs, 33(1), 31-46. https://doi.org/10.1007/s40263-018-0594-5

Guerdjikova, A., Mori, N., Casuto, L., & McElroy, S. (2019). Update on Binge Eating Disorder. The Medical Clinics of North America, 103(4), 669-680. https://doi.org/10.1016/j.mcna.2019.02.003

Guerdjikova, A., Blom, T., Mori, N., Matthews, A., Cummings, T., Casuto, L., & McElroy, S. (1969). Lisdexamfetamine in Pediatric Binge Eating Disorder: A Retrospective Chart Review. Clinical Neuropharmacology, 42(6), 214-216. https://doi.org/10.1097/WNF.0000000000000367 (Original work published 1969)

Guerdjikova, A., Romo-Nava, F., Blom, T., Mori, N., & McElroy, S. (2021). Study protocol and rationale for a randomized, placebo-controlled trial of solriamfetol to treat binge eating disorder. Contemporary Clinical Trials, 110, 106587. https://doi.org/10.1016/j.cct.2021.106587